Serous pigment epithelial detachment in age-related macular degeneration: Comparison of different treatments

Eye

Volumn 23, Issue 12, 2009, Pages 2163-2168

  Lommatzsch, A ^a   Heimes, B ^a   Gutfleisch, M ^a   Spital, G ^a   Zeimer, M ^a   Pauleikhoff, D ^a  

^a ST FRANZISKUS HOSPITAL   (Germany)

Author keywords

Age related macular degeneration; Bevacizumab; Pegaptanib; Photodynamic therapy; Ranibizumab; Retinal pigment epithelium detachment

Indexed keywords

BEVACIZUMAB; PEGAPTANIB; RANIBIZUMAB; TRIAMCINOLONE ACETONIDE;

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RETINA TEAR; VISION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; APTAMERS, NUCLEOTIDE; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FOVEA CENTRALIS; HUMANS; IMMUNOLOGIC FACTORS; INTRAVITREAL INJECTIONS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PIGMENT EPITHELIUM OF EYE; RETINAL DETACHMENT; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY;

EID: 72749105165     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.425     Document Type: Article

References (44)

1. Bressler NM. Age-related macular degeneration is the leading cause of blindness. JAMA 2004; 291(15): 1900-1901.
2. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995; 39(5): 367-374.
3. Bird AC. Pathogenesis of lesions in late age-related macular disease.. J Fr Ophtalmol 2005; 28(9): 984.
4. Holz FG, Pauleikhoff D, Klein R, Bird AC. Pathogenesis of lesions in late age-related macular disease. Am J Ophthalmol 2004; 137(3): 504-510.
5. Shimada H, Kawamura A, Mori R, Yuzawa M. Clinicopathological findings of retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 2007; 245(2): 295-300.
6. Ahlers C, Michels S, Beckendorf A, Birngruber R, Schmidt-Erfurth U. Three-dimensional imaging of pigment epithelial detachment in age-related macular degeneration using optical coherence tomography, retinal thickness analysis and topographic angiography. Graefes Arch Clin Exp Ophthalmol 2006; 244(10): 1233-1239.
7. Gass JD. Serous retinal pigment epithelial detachment with a notch. A sign of occult choroidal neovascularization. Retina 1984; 4(4): 205-220.
8. Bird AC, Marshall J. Retinal pigment epithelial detachments in the elderly. Trans Ophthalmol Soc UK 1986; 105: 674-682.
9. Bird AC. Doyne Lecture. Pathogenesis of retinal pigment epithelial detachment in the elderly; the relevance of Bruch's membrane change. Eye 1991; 5: 1-12.
10. Lafaut BA, Aisenbrey S, Vanden Broecke C, Krott R, Jonescu-Cuypers CP, Reynders S et al. Clinicopathological correlation of retinal pigment epithelial tears in exudative age related macular degeneration: pretear, tear, and scarred tear. Br J Ophthalmol 2001; 85(4): 454-460.
11. Pauleikhoff D, Loffert D, Spital G, Radermacher M, Dohrmann J, Lommatzsch A et al. Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol 2002; 240(7): 533-538.
12. Cohen SY, Creuzot-Garcher C, Darmon J, Desmettre T, Korobelnik JF, Levrat F et al. Types of choroidal neovascularisation in newly diagnosed exudative agerelated macular degeneration. Br J Ophthalmol 2007; 91(9): 1173-1176.
13. Zayit-Soudry S, Moroz I, Loewenstein A. Retinal pigment epithelial detachment. Surv Ophthalmol 2007; 52(3): 227-243.
14. Gelisken F, Inhoffen W, Partsch M, Schneider U, Kreissig I. Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization. Am J Ophthalmol 2001; 131(4): 518-520.
15. Pece A, Isola V, Vadala M, Calori G. Photodynamic therapy with verteporfin for choroidal neovascularization associated with retinal pigment epithelial detachment in age-related macular degeneration. Retina 2007; 27(3): 342-348.
16. Bird AC. Treatment of pigment epithelial detachments in the elderly. Trans Ophthalmol Soc NZ 1983; 35: 73-75.
17. Goldstein M, Heilweil G, Barak A, Loewenstein A. Retinal pigment epithelial tear following photodynamic therapy for choroidal neovascularization secondary to AMD. Eye 2005; 19(12): 1315-1324.
18. Axer-Siegel R, Ehrlich R, Avisar I, Kramer M, Rosenblatt I, Priel E et al. Combined photodynamic therapy and intravitreal triamcinolone acetonide injection for neovascular age-related macular degeneration with pigment epithelium detachment. Ophthalmic Surg Lasers Imaging 2006; 37(6): 455-461.
19. Krebs I, Binder S, Stolba U. A new treatment regimen in combined intravitreal injection of triamcinolone acetonide and photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 2006; 244(7): 863-867.
20. Bashshur ZF, Haddad ZA, Schakal A, Jaafar RF, Saab M, Noureddin BN. Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: a one-year prospective study. Am J Ophthalmol 2008; 145(2): 249-256.
21. Ladas ID, Kotsolis AI, Papakostas TD, Rouvas AA, Karagiannis DA, Vergados I. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration. Retina 2007; 27(7): 891-896.
22. Lai TY, Chan WM, Liu DT, Lam DS. Ranibizumab for retinal angiomatous proliferation in neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2007; 245(12): 1877-1880.
23. Weinberger AW, Thiel M, Mohammadi B, Theofylaktopoulos I, Thumann G, Walter P. Retinal pigment epithelium tears after intravitreal bevacizumab in pigment epithelium detachment. Am J Ophthalmol 2007; 144(2): 294-296.
24. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trialsFTAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol 1999; 117(10): 1329-1345.
25. Verteporfin In Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularizationFverteporfin in photodynamic therapy report 2. Am J Ophthalmol 2001; 131(5): 541-560.
26. Jaissle GB, Szurman P, Bartz-Schmidt KU. Recommendation for the implementation of intravitreal injectionsFstatement of the German Retina Society, the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA). Klin Monatsbl Augenheilkd 2005; 222(5): 390-395.
27. Yannuzzi LA, Negrao S, Iida T, Carvalho C, Rodriguez- Coleman H, Slakter J et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001; 21(5): 416-434.
28. Spital G, Brumm G, Radermacher M, Muller C, Lommatzsch A, Pauleikhoff D. Volume determination of pigment epithelium detachment in AMD by laser scanning tomography. Ophthalmologe 2000; 97(3): 173-180.
29. Lee WK, Park YH, Lee PY. Neovascularization associated with large retinal pigment epithelial detachment in elderly Korean patients: subdivision according to indocyanine green angiographic features. Jpn J Ophthalmol 2007; 51(3): 216-223.
30. Sallet G, Lafaut BA, De Laey JJ. Indocyanine green angiography and age-related serous pigment epithelial detachment. Graefes Arch Clin Exp Ophthalmol 1996; 234(1): 25-33.
31. Truong SN, Alam S, Zawadzki RJ, Choi SS, Telander DG, Park SS et al. High resolution Fourier-domain optical coherence tomography of retinal angiomatous proliferation. Retina 2007; 27(7): 915-925.
32. Gomez-Ulla F, Abraldes MJ, Fernandez M, Olmedo M. Successful treatment of retinal angiomatous proliferation by photodynamic therapy. Optom Vis Sci 2006; 83(8): 546-549.
33. Freund KB, Klais CM, Eandi CM, Ober MD, Goldberg DE, Sorenson JA et al. Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation. Arch Ophthalmol 2006; 124(4): 487-492.
34. Fung AE, Rosenfeld PJ, Reichel E. The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br J Ophthalmol 2006; 90(11): 1344-1349.
35. Gragoudas ES, Adamis AP, Cunningham Jr ET, Feinsod M, Guyer DR. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004; 351(27): 2805-2816.
36. Chakravarthy U, Adamis AP, Cunningham Jr ET, Goldbaum M, Guyer DR, Katz B et al. Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. Ophthalmology 2006; 113(9): 1508 e1501-e1525.
37. Costagliola C, Romano MR, dell'Omo R, Cipollone U, Polisena P. Intravitreal bevacizumab for the treatment of retinal angiomatous proliferation. Am J Ophthalmol 2007; 144(3): 449-451.
38. Gelisken F, Ziemssen F, VoelkerM, Bartz-Schmidt KU, Inhoffen W. Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration. Eye 2008 [e-pub ahead of print].
39. Joeres S, Heussen FM, Treziak T, Bopp S, Joussen AM. Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 2007; 245(11): 1597-1602.
40. Meyerle CB, Freund KB, Iturralde D, Spaide RF, Sorenson JA, Slakter JS et al. Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation. Retina 2007; 27(4): 451-457.
41. Chang LK, Flaxel CJ, Lauer AK, Sarraf D. RPE tears after pegaptanib treatment in age-related macular degeneration. Retina 2007; 27(7): 857-863.
42. Dhalla MS, Blinder KJ, Tewari A, Hariprasad SM, Apte RS. Retinal pigment epithelial tear following intravitreal pegaptanib sodium. Am J Ophthalmol 2006; 141(4): 752-754.
43. Kook D,Wolf A, Neubauer AS, Haritoglou C, Priglinger SG, Kampik A et al. Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD. Frequency and progress. Ophthalmologe 2008; 105(2): 158-164.
44. Spandau UH, Jonas JB. Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration. Am J Ophthalmol 2006; 142(6): 1068-1070.